Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Prana Biotechnology Ltd (NASDAQ:PRAN)

0.939
Delayed Data
As of Aug 31
 +0.009 / +0.97%
Today’s Change
0.70
Today|||52-Week Range
2.94
-42.74%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$45.5M

Company Description

Prana Biotechnology Ltd. is focused on the research and development of treatments for Alzheimer's, Huntington's disease and other major age related degenerative disorders. It is developed a proprietary library of class chemical compounds, which is combined with a drug development program to explore novel therapeutics in multiple disease indications. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Parkville, Australia.

Contact Information

Prana Biotechnology Ltd.
369 Royal Parade
Parkville Victoria (vic) 3052
P:(139) 349-4906
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Geoffrey Paul KemplerExecutive Chairman & Chief Executive Officer
Dianne AngusChief Operating Officer
Phillip A. HainsChief Financial Officer